Presentation is loading. Please wait.

Presentation is loading. Please wait.

Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study  Cesare Gridelli, MD, Carmine Ferrara, MD, Ciro Guerriero, MD, Salvatore.

Published byGunnar Sundqvist Modified over 6 years ago

Similar presentations

Presentation on theme: "Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study  Cesare Gridelli, MD, Carmine Ferrara, MD, Ciro Guerriero, MD, Salvatore."— Presentation transcript:

1 Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study 
Cesare Gridelli, MD, Carmine Ferrara, MD, Ciro Guerriero, MD, Salvatore Palazzo, MD, Giuseppe Grasso, MD, Ida Pavese, MD, Francesco Satta, MD, Emilio Bajetta, MD, Diego Cortinovis, MD, Fausto Barbieri, MD, Vittorio Gebbia, MD, Francesco Grossi, MD, Silvia Novello, MD, Editta Baldini, MD, Giampietro Gasparini, MD, Walter Latino, MD, Emilia Durante, MD, Lucio Giustini, MD, Cristina Negrini, MD  Journal of Thoracic Oncology  Volume 2, Issue 6, Pages (June 2007) DOI: /01.JTO f3 Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Study flow chart.
Journal of Thoracic Oncology 2007 2, DOI: ( /01.JTO f3) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Lung Cancer Symptoms subscale. Symptoms changes between baseline (T0) and last observation (T3). Journal of Thoracic Oncology 2007 2, DOI: ( /01.JTO f3) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Average trimonthly costs per patients in the two treatment groups. Journal of Thoracic Oncology 2007 2, DOI: ( /01.JTO f3) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Monthly assistance costs per caregiver type. The nursing component of principal caregiver activities is presented separately from the other tasks. Journal of Thoracic Oncology 2007 2, DOI: ( /01.JTO f3) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 5 Monthly informal assistance cost (principal caregiver tasks, excluding housekeeping) per metastasis presence and localization. Journal of Thoracic Oncology 2007 2, DOI: ( /01.JTO f3) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study  Cesare Gridelli, MD, Carmine Ferrara, MD, Ciro Guerriero, MD, Salvatore."

Similar presentations

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
A Hole in the Heart Journal of Thoracic Oncology

A Hole in the Heart Journal of Thoracic Oncology
Su K. Metcalfe, MD, MPH, Michael T

Su K. Metcalfe, MD, MPH, Michael T
Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer  Timothy R. Wassenaar, MD, Jens C.

Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer  Timothy R. Wassenaar, MD, Jens C.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?  Adrian G.

Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?  Adrian G.
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in.

Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in.
SC17.02 Lung Cancer in China: Challenges and Perspectives

SC17.02 Lung Cancer in China: Challenges and Perspectives
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD 

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD 
Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study  Cesare Gridelli, MD, Carmine Ferrara, MD, Ciro Guerriero, MD, Salvatore.

Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study  Cesare Gridelli, MD, Carmine Ferrara, MD, Ciro Guerriero, MD, Salvatore.
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
Hedgehog Signaling Pathway and Lung Cancer

Hedgehog Signaling Pathway and Lung Cancer
Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients  Hes A.P. Brokx, MD, Otto Visser, MD, PhD,

Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients  Hes A.P. Brokx, MD, Otto Visser, MD, PhD,
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced.

Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced.
Gefitinib (IRESSA) with Vinorelbine or Vinorelbine/Cisplatin for Chemotherapy-Naive Non-small Cell Lung Cancer Patients  Jean-Louis Pujol, MD, Patrick.

Gefitinib (IRESSA) with Vinorelbine or Vinorelbine/Cisplatin for Chemotherapy-Naive Non-small Cell Lung Cancer Patients  Jean-Louis Pujol, MD, Patrick.

Similar presentations

Ads by Google